Docoh
Loading...

NBTX Nanobiotix

Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people committed to making a difference for humanity. The company’s philosophy is rooted in the concept of pushing past the boundaries of what is known to expand possibilities for human life.

NBTX stock data

(
)

Calendar

7 Apr 21
24 Oct 21
31 Dec 21
Quarter (USD)
Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Nanobiotix earnings reports.

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

19.8% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 11 11
Opened positions 0 10 EXIT
Closed positions 0 0
Increased positions 1 0 NEW
Reduced positions 2 0 NEW
13F shares
Current Prev Q Change
Total value 100.4M 106.71M -5.9%
Total shares 6.88M 6.9M -0.2%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Artal International S.C.A. 2.03M $33.54M 0.0%
Baillie Gifford & Co 1.4M $19.29M 0.0%
Perceptive Advisors 1.06M $14.6M 0.0%
Artal 1M $13.78M 0.0%
Tybourne Capital Management 750K $10.34M 0.0%
Orbimed Advisors 500K $6.89M 0.0%
Woodline Partners 59.99K $827K -7.0%
UBS UBS Group AG - Registered Shares 59.79K $824K -14.8%
Millennium Management 22.23K $306K +0.7%
MS Morgan Stanley 300 $4K 0.0%
Largest transactions
Shares Bought/sold Change
UBS UBS Group AG - Registered Shares 59.79K -10.39K -14.8%
Woodline Partners 59.99K -4.52K -7.0%
Millennium Management 22.23K +151 +0.7%
Proequities 0 0
MS Morgan Stanley 300 0 0.0%
Artal 1M 0 0.0%
Orbimed Advisors 500K 0 0.0%
Baillie Gifford & Co 1.4M 0 0.0%
Artal International S.C.A. 2.03M 0 0.0%
Perceptive Advisors 1.06M 0 0.0%

Financial report summary

?
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg

Proxies

No filings